Literature DB >> 34652432

Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3).

Mary K Townsend1, Britton Trabert2, Renée T Fortner3, Alan A Arslan4, Julie E Buring5,6,7, Brian D Carter8, Graham G Giles9,10,11, Sarah R Irvin12, Michael E Jones13, Rudolf Kaaks3, Victoria A Kirsh14,15, Synnove F Knutsen16, Woon-Puay Koh17,18, James V Lacey19, Hilde Langseth20,21, Susanna C Larsson22, I-Min Lee5,6,7, María Elena Martínez23, Melissa A Merritt24, Roger L Milne9,10,11, Katie M O'Brien25, Michael J Orlich16, Julie R Palmer26, Alpa V Patel8, Ulrike Peters27,28, Jenny N Poynter29, Kim Robien30, Thomas E Rohan31, Lynn Rosenberg26, Sven Sandin32,33,34, Dale P Sandler25, Leo J Schouten35, V Wendy Setiawan36, Anthony J Swerdlow37, Giske Ursin38,39,40, Piet A van den Brandt35, Kala Visvanathan41,42, Elisabete Weiderpass43, Alicja Wolk22,44, Jian-Min Yuan45,46, Anne Zeleniuch-Jacquotte47, Shelley S Tworoger1, Nicolas Wentzensen12.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 34652432      PMCID: PMC9425513          DOI: 10.1093/ije/dyab211

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   9.685


× No keyword cloud information.
  23 in total

1.  High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.

Authors:  Lauren C Peres; Adrianne R Mallen; Mary K Townsend; Elizabeth M Poole; Britton Trabert; Naomi E Allen; Alan A Arslan; Laure Dossus; Renée T Fortner; Inger T Gram; Patricia Hartge; Annika Idahl; Rudolf Kaaks; Marina Kvaskoff; Anthony M Magliocco; Melissa A Merritt; J Ramón Quirós; Anne Tjonneland; Antonia Trichopoulou; Rosario Tumino; Carla H van Gils; Kala Visvanathan; Nicolas Wentzensen; Anne Zeleniuch-Jacquotte; Shelley S Tworoger
Journal:  Cancer Res       Date:  2019-08-28       Impact factor: 12.701

2.  Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity.

Authors:  Clara Bodelon; J Keith Killian; Joshua N Sampson; William F Anderson; Rayna Matsuno; Louise A Brinton; Jolanta Lissowska; Michael S Anglesio; David D L Bowtell; Jennifer A Doherty; Susan J Ramus; Aline Talhouk; Mark E Sherman; Nicolas Wentzensen
Journal:  Clin Cancer Res       Date:  2019-05-29       Impact factor: 12.531

Review 3.  The National Cancer Institute Cohort Consortium: An International Pooling Collaboration of 58 Cohorts from 20 Countries.

Authors:  Anthony J Swerdlow; Chinonye E Harvey; Roger L Milne; Camille A Pottinger; Celine M Vachon; Lynne R Wilkens; Susan M Gapstur; Mattias Johansson; Elisabete Weiderpass; Deborah M Winn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-17       Impact factor: 4.254

4.  Predictors of survival trajectories among women with epithelial ovarian cancer.

Authors:  Lauren C Peres; Sweta Sinha; Mary K Townsend; Brooke L Fridley; Beth Y Karlan; Susan K Lutgendorf; Eileen Shinn; Anil K Sood; Shelley S Tworoger
Journal:  Gynecol Oncol       Date:  2019-12-12       Impact factor: 5.482

5.  Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.

Authors:  Britton Trabert; Elizabeth M Poole; Emily White; Kala Visvanathan; Hans-Olov Adami; Garnet L Anderson; Theodore M Brasky; Louise A Brinton; Renee T Fortner; Mia Gaudet; Patricia Hartge; Judith Hoffman-Bolton; Michael Jones; James V Lacey; Susanna C Larsson; Gerardo G Mackenzie; Leo J Schouten; Dale P Sandler; Katie O'Brien; Alpa V Patel; Ulrike Peters; Anna Prizment; Kim Robien; V Wendy Setiawan; Anthony Swerdlow; Piet A van den Brandt; Elisabete Weiderpass; Lynne R Wilkens; Alicja Wolk; Nicolas Wentzensen; Shelley S Tworoger
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

6.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Authors:  Saundra S Buys; Edward Partridge; Amanda Black; Christine C Johnson; Lois Lamerato; Claudine Isaacs; Douglas J Reding; Robert T Greenlee; Lance A Yokochi; Bruce Kessel; E David Crawford; Timothy R Church; Gerald L Andriole; Joel L Weissfeld; Mona N Fouad; David Chia; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Patricia Hartge; Paul F Pinsky; Claire S Zhu; Grant Izmirlian; Barnett S Kramer; Anthony B Miller; Jian-Lun Xu; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  JAMA       Date:  2011-06-08       Impact factor: 157.335

7.  Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.

Authors:  Ren-Chin Wu; Pei Wang; Shiou-Fu Lin; Ming Zhang; Qianqian Song; Tiffany Chu; Brant G Wang; Robert J Kurman; Russell Vang; Kenneth Kinzler; Cristian Tomasetti; Yuchen Jiao; Ie-Ming Shih; Tian-Li Wang
Journal:  J Pathol       Date:  2019-02-15       Impact factor: 7.996

8.  Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Authors:  Ruth M Pfeiffer; Yikyung Park; Aimée R Kreimer; James V Lacey; David Pee; Robert T Greenlee; Saundra S Buys; Albert Hollenbeck; Bernard Rosner; Mitchell H Gail; Patricia Hartge
Journal:  PLoS Med       Date:  2013-07-30       Impact factor: 11.069

9.  Prognostic gene expression signature for high-grade serous ovarian cancer.

Authors:  J Millstein; T Budden; E L Goode; M S Anglesio; A Talhouk; M P Intermaggio; H S Leong; S Chen; W Elatre; B Gilks; T Nazeran; M Volchek; R C Bentley; C Wang; D S Chiu; S Kommoss; S C Y Leung; J Senz; A Lum; V Chow; H Sudderuddin; R Mackenzie; J George; S Fereday; J Hendley; N Traficante; H Steed; J M Koziak; M Köbel; I A McNeish; T Goranova; D Ennis; G Macintyre; D Silva De Silva; T Ramón Y Cajal; J García-Donas; S Hernando Polo; G C Rodriguez; K L Cushing-Haugen; H R Harris; C S Greene; R A Zelaya; S Behrens; R T Fortner; P Sinn; E Herpel; J Lester; J Lubiński; O Oszurek; A Tołoczko; C Cybulski; J Menkiszak; C L Pearce; M C Pike; C Tseng; J Alsop; V Rhenius; H Song; M Jimenez-Linan; A M Piskorz; A Gentry-Maharaj; C Karpinskyj; M Widschwendter; N Singh; C J Kennedy; R Sharma; P R Harnett; B Gao; S E Johnatty; R Sayer; J Boros; S J Winham; G L Keeney; S H Kaufmann; M C Larson; H Luk; B Y Hernandez; P J Thompson; L R Wilkens; M E Carney; B Trabert; J Lissowska; L Brinton; M E Sherman; C Bodelon; S Hinsley; L A Lewsley; R Glasspool; S N Banerjee; E A Stronach; P Haluska; I Ray-Coquard; S Mahner; B Winterhoff; D Slamon; D A Levine; L E Kelemen; J Benitez; J Chang-Claude; J Gronwald; A H Wu; U Menon; M T Goodman; J M Schildkraut; N Wentzensen; R Brown; A Berchuck; G Chenevix-Trench; A deFazio; S A Gayther; M J García; M J Henderson; M A Rossing; A Beeghly-Fadiel; P A Fasching; S Orsulic; B Y Karlan; G E Konecny; D G Huntsman; D D Bowtell; J D Brenton; J A Doherty; P D P Pharoah; S J Ramus
Journal:  Ann Oncol       Date:  2020-05-28       Impact factor: 51.769

10.  Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort Consortium.

Authors:  Shelley S Tworoger; Leo J Schouten; Renée T Fortner; Megan S Rice; Synnove F Knutsen; Michael J Orlich; Kala Visvanathan; Alpa V Patel; Mia M Gaudet; Anne Tjønneland; Marina Kvaskoff; Rudolf Kaaks; Antonia Trichopolou; Valeria Pala; N Charlotte Onland-Moret; Inger T Gram; Pilar Amiano; Annika Idahl; Naomi E Allen; Elisabete Weiderpass; Jenny N Poynter; Kim Robien; Graham G Giles; Roger L Milne; Veronica W Setiawan; Melissa A Merritt; Piet A van den Brandt; Anne Zeleniuch-Jacquotte; Alan A Arslan; Katie M O'Brien; Dale P Sandler; Alicja Wolk; Niclas Håkansson; Holly R Harris; Britton Trabert; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-30       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.